Sign Out
Hypersensitivity to the active substance or to any of the excipients.
Hepatic impairment (i.e. cirrhosis or active liver disease) or transaminases exceeding 3X upper limit of normal.
Concomitant use of potent CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin).
Continue with Google